Elisabetta Abruzzese, Alessandro Gozzetti, Sara Galimberti, Malgorzata Monika Trawinska, Tommaso Caravita, Agostina Siniscalchi, Giulia Cervetti, Alessandro Mauriello, Angela Maria Coletta and Paolo De Fabritiis Characterization of Ph-negative abnormal clones emerging during imatinib therapy Cancer 109
Version of Record online: 14 MAY 2007 | DOI: 10.1002/cncr.22699
Patients with Philadelphia chromosome clones emerging during imatinib therapy were studied and followed over time. None of the patients presented with clinical and laboratory signs of myelodysplastic syndrome after up to 49 months of follow-up.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field